Frontiers in Endocrinology (Sep 2021)

Catecholaminergic Crisis After a Bleeding Complication of COVID-19 Infection: A Case Report

  • Angel Rebollo-Román,
  • Angel Rebollo-Román,
  • Maria R. Alhambra-Expósito,
  • Maria R. Alhambra-Expósito,
  • Yiraldine Herrera-Martínez,
  • F. Leiva-Cepas,
  • F. Leiva-Cepas,
  • Carlos Alzas,
  • Concepcion Muñoz-Jiménez,
  • Concepcion Muñoz-Jiménez,
  • R. Ortega-Salas,
  • R. Ortega-Salas,
  • María J. Molina-Puertas,
  • María J. Molina-Puertas,
  • Maria A. Gálvez-Moreno,
  • Maria A. Gálvez-Moreno,
  • Aura D. Herrera-Martínez,
  • Aura D. Herrera-Martínez

DOI
https://doi.org/10.3389/fendo.2021.693004
Journal volume & issue
Vol. 12

Abstract

Read online

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) presents in some cases with hemostatic and thrombotic complications. Pheochromocytomas are unusual, though potentially lethal tumors. Herein we describe the first case of hemorrhage in a pheochromocytoma related to SARS-CoV-2 infection. A 62-year-old man consulted for syncope, fever, and palpitations. He was diagnosed with SARS-CoV-2 pneumonia and presented with a hemorrhage in a previously unknown adrenal mass, which resulted in a catecholaminergic crisis. Medical treatment and surgery were required for symptom control and stabilization. We hereby alert clinicians to watch for additional/unreported clinical manifestations in COVID-19 infection.

Keywords